• No results found

Duration of antibiotic treatment and symptom recovery in community-acquired pneumonia - Contents

N/A
N/A
Protected

Academic year: 2021

Share "Duration of antibiotic treatment and symptom recovery in community-acquired pneumonia - Contents"

Copied!
3
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

UvA-DARE is a service provided by the library of the University of Amsterdam (https://dare.uva.nl)

UvA-DARE (Digital Academic Repository)

Duration of antibiotic treatment and symptom recovery in community-acquired

pneumonia

El Moussaoui, R.

Publication date

2006

Link to publication

Citation for published version (APA):

El Moussaoui, R. (2006). Duration of antibiotic treatment and symptom recovery in

community-acquired pneumonia.

General rights

It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons).

Disclaimer/Complaints regulations

If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible.

(2)

Chapter 1 Introduction 7

Chapter 2 Short Course Antibiotic Treatment in Acute Exacerbations of Chronic

Brochitis and COPD: meta-analysis of double-blind studies

Submitted

19

Chapter 3 The Development and Validation of a Short Questionnaire in

Community-acquired Pneumonia

Thorax 2004; 59 (8): 591-95

35

Chapter 4 Effectiveness of Discontinuing Antibiotic Treatment after Three Days

versus Eight Days in mild to moderate-severe Community-acquired Pneumonia: randomised, double blind study

BMJ 2006; 332:1355-62

Chapter 5 Discontinuing Antibiotic Treatment after Three Days versus Eight Days

in mild to moderate-severe Community-acquired Pneumonia: an economic evaluation.

Submitted

51

67

Chapter 6 Determinants of Early Symptom Recovery in Patients with

Community-acquired Pneumonia

Submitted

79

Chapter 7 Long-term Symptom Recovery and Health-Related Quality of Life in

Patients with mild to moderate-severe Community-acquired Pneumonia

Chest 2006; 130: 1165-1172

91

Chapter 8 Large Variability in Outcome Measures in Community-acquired

Pneumonia (CAP) Antibiotic Treatment Trials - a systematic review

Submitted 105 Chapter 9 Chapter 10 Summary Samenvatting 119 127 Dankwoord 135

(3)

Referenties

GERELATEERDE DOCUMENTEN

(2005) Folding Trp-cage to NMR resolution native structure using a coarse grained protein model Biophys.. (2008) Contrasting disease and non-disease protein aggregation by

If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of

As a first step towards understanding fibril formation of these block copolymers we pre- dicted the structure of the silk-based block in water under fibril-forming conditions (low

Simulaties met een atomistisch omschrijvingsniveau kunnen niet gebruikt worden om het zelfassemblage proces van de zijde-gebaseerde blok copolymeren te bestuderen.. Daarom hebben we

From peptide chains to chains of peptides: multiscale modelling of self- assembling fibril-forming polypeptides..

Pe- ter Tieleman she carried out a project entitled “The behaviour of a fluorescent probe covalently linked to M13 major coat protein in bilayer environment and its implications

Mijn kamergenoten, eerst Arjen en Elske, toen Aimee, vervolgens Francesco, Rosanne en Kush en de laatste maanden ook Lizhe en Weina wil ik bedanken voor alle koffie die ze voor me

In the DOA study end-stage hip or knee OA patients who experienced neuropathic-like symptoms were included (as a proxy for a centrally sensitized pain status) to receive